Page 25 - S&p Bse Sensex

Vedanta shares rise 2% as board set to consider second interim dividend

Vedanta shares gained over 2 per cent on Tuesday after the company said its board will meet to consider an interim dividend for FY26

Spandana Sphoorthy Financial reports weak Q1 results; analysts weigh in

Most brokerages have maintained their rating on the stock; however, they have cut the target price; check out target here

CSB Bank shares tumble 8% as Q1 NIM narrows; stock down 18% in 3 days

CSB Bank shares fell 8 per cent after the lender's net interest margin (NIM) narrowed in the June quarter

Deepak Nitrite shares slip 4% on posting weak Q1 results; key details

Deepak Nitrite shares slipped 4.3 per cent on Wednesday, August 14, 2025, after the company posted weak Q1 results

Texmaco Rail shares decline 4% as Q1 profit growth halves; details here

Texmaco Rail shares fell 4 per cent after its profit growth nearly halved in the June quarter, while revenue declined over 15 per cent

Nuvama Wealth shares rise 3% after in-line Q1 results; should you buy?

Nuvama Wealth shares rose 3 per cent after its June-quarter earnings came in line with the street estimates

Shilpa Medicare share jumps 4% on 1:1 bonus issue; check record date here

Shilpa Medicare shares rose after the company announced a 1:1 bonus issue, with the Board approving the proposal in its meeting on August 13, 2025.

Mixed signals after ONGC Q1 nos; what's the best move for investors now?

On a standalone basis, ONGC's gross revenue dropped 9.3 per cent Y-o-Y to ₹32,003 crore, while net profit fell 10.2 per cent to ₹8,024 crore from ₹8,938 crore last year.

Infosys shares rise 2% on launching JV with Telstra; stock details here

Infosys shares rose nearly 2 per cent after it announced a joint venture with Telstra, where it will invest around ₹1,300 crore

Smallcap travel related stock zooms 66% in 3 days. Do you own?

Yatra Online shares hit a 52-week high of ₹159.17, surging 16 per cent in Wednesday's intra-day trade amid heavy volumes

Premier Explosives shares soar 16% as Q1 profit doubles; key numbers here

Premier Explosives shares rose over 16 per cent after June quarter profit doubled; the company plans to raise ₹300 crore

Allcargo Logistics shares tumble 6% on Q1 loss; check details here

Allcargo Logistics shares fell over 6 per cent on reporting a net loss of ₹99.9 crore for the quarter ended June 2025

Cochin Shipyard shares rise 3% despite analyst caution; should you sell?

Antique Stock Broking said it expects Cochin Shipyard's revenue growth to slow in the coming quarters due to a stagnant order book

Analysts at Motilal Oswal suggest buying these three stocks today; details

Nifty outlook: On option front, Maximum Call OI is at 24600 then 24700 strike while Maximum Put OI is at 24500 then 24400 strike.

Trading guide: Here are key Nifty levels to watch today; two ETFs to buy

The 24340 level, where recent swing lows were registered, continues to be the support for the Nifty. On the upside, today's high of 24702 will now act as a short-term resistance level.

Medi Assist shares surge 12% after block trades; check likely seller here

Medi Assist Healthcare shares rose 12 per cent after about 11.1 million shares changed hands in two blocks

What are brokerages saying about this hotel stock after its Q1 results?

Nuvama said the hotel operator's Q1 growth was "driven by improving average room rates (ARRs) and occupancies across portfolio brands" despite geopolitical tensions and air travel disruptions.

Why did Titagarh Rail Systems shares rise 5% despite posting weak Q1 nos?

Titagarh Rail Systems shares advanced 5.2 per cent on Tuesday, an intra-day high at ₹818 per share on BSE, despite posting weak Q1; here's why

Man Industries shares plunge 10% as revenue drops; check Q1 breakdown here

Man Industries shares fell 10 per cent after its June quarter revenue marginally dropped; profit, however, rose 45 per cent

Pfizer share price up 3% on rolling out this vaccine; key details inside

Pfizer's share price gained today after the company announced the launch of its next-generation 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.